McKracken,
The median survival benefit of Provenge has been understated as some on the control group who relapsed were given frozen Provenge.
Taking this into account, the median was over 7months.
http://seekingalpha.com/article/332382-provenge-is-probably-more-effective-than-we-think
(Median survival means 50% of patients will live longer than the stated time, some significantly longer.)
food for thought, page-42
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.005(1.72%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.8¢ | 29.0¢ | $539.5K | 1.834M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 214062 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 469318 | 5 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |